Cargando…
_version_ 1783581841837522944
author Galvis, Virgilio
Spinelli, Francesca Romana
Tello, Alejandro
Sossa, Claudia L.
Higuera, Juan D.
Gómez, Edgar D.
Serrano, Sergio E.
Camacho, Paul A.
Velez, Federico G.
author_facet Galvis, Virgilio
Spinelli, Francesca Romana
Tello, Alejandro
Sossa, Claudia L.
Higuera, Juan D.
Gómez, Edgar D.
Serrano, Sergio E.
Camacho, Paul A.
Velez, Federico G.
author_sort Galvis, Virgilio
collection PubMed
description
format Online
Article
Text
id pubmed-7489223
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SEPAR. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-74892232020-09-15 Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials Galvis, Virgilio Spinelli, Francesca Romana Tello, Alejandro Sossa, Claudia L. Higuera, Juan D. Gómez, Edgar D. Serrano, Sergio E. Camacho, Paul A. Velez, Federico G. Arch Bronconeumol Scientific Letter SEPAR. Published by Elsevier España, S.L.U. 2020-09 2020-09-14 /pmc/articles/PMC7489223/ /pubmed/33994644 http://dx.doi.org/10.1016/j.arbr.2020.05.010 Text en © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Scientific Letter
Galvis, Virgilio
Spinelli, Francesca Romana
Tello, Alejandro
Sossa, Claudia L.
Higuera, Juan D.
Gómez, Edgar D.
Serrano, Sergio E.
Camacho, Paul A.
Velez, Federico G.
Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
title Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
title_full Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
title_fullStr Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
title_full_unstemmed Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
title_short Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
title_sort hydroxychloroquine as prophylaxis for coronavirus sars-cov-2 infection: review of the ongoing clinical trials
topic Scientific Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489223/
https://www.ncbi.nlm.nih.gov/pubmed/33994644
http://dx.doi.org/10.1016/j.arbr.2020.05.010
work_keys_str_mv AT galvisvirgilio hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT spinellifrancescaromana hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT telloalejandro hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT sossaclaudial hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT higuerajuand hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT gomezedgard hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT serranosergioe hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT camachopaula hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials
AT velezfedericog hydroxychloroquineasprophylaxisforcoronavirussarscov2infectionreviewoftheongoingclinicaltrials